Literature DB >> 29273285

The Danish Head and Neck Cancer fast-track program: a tertiary cancer centre experience.

Anders B Roennegaard1, Tine Rosenberg2, Kristine Bjørndal1, Jens Ahm Sørensen3, Jørgen Johansen4, Christian Godballe1.   

Abstract

INTRODUCTION: During the 1990s, all Nordic countries except for Denmark experienced a general increase in 5-year survival rates for cancer patients. In 2007, the Danish National Board of Health in collaboration with national multidisciplinary cancer groups and the Danish regions initiated fast-track clinical pathway solutions.
OBJECTIVES: The objectives of this study were 1) to present the setup of the head and neck cancer (HNC) fast-track program at Odense University Hospital (OUH) as an example of the Danish model and 2) to present patient characteristics, diagnostic outcome, cancer detection rate, and duration of the fast-track patient courses.
MATERIALS AND METHODS: From 1st July 2012 to 1st September 2015, all patients referred to the HNC fast-track program at OUH for diagnostics and treatment were consecutively included in the study resulting in 3165 patient courses.
RESULTS: The overall malignancy detection rate was 40.6% and for HNC it was 29.2%. The overall median fast-track course duration was 12 days (range 0-74). Overall 2990 (94.5%) of 3165 patients completed their fast-track course within the maximally permitted course duration. DISCUSSION AND
CONCLUSION: Based on our findings, it was concluded that: 1) a HNC fast-track program build on pre-booked slots for diagnostics and treatment is feasible and can secure acceptable course durations for more than 90% of patient courses, 2) by using private ENT specialists as a 'filter-function', an acceptable detection rate can be achieved.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Denmark; Fast-track program; Head and neck cancer; Multidisciplinary

Mesh:

Year:  2017        PMID: 29273285     DOI: 10.1016/j.ejca.2017.10.038

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  4 in total

1.  Risk of Malignancy in FDG-Avid Thyroid Incidentalomas on PET/CT: A Prospective Study.

Authors:  Chadi Nimeh Abdel-Halim; Tine Rosenberg; Kristine Bjørndal; Anders Rørbæk Madsen; John Jakobsen; Helle Døssing; Mette Bay; Anders Thomassen; Anne Lerberg Nielsen; Christian Godballe
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Salivary gland carcinoma in Denmark: a national update and follow-up on incidence, histology, and outcome.

Authors:  Marie Westergaard-Nielsen; Christian Godballe; Jesper Grau Eriksen; Stine Rosenkilde Larsen; Katalin Kiss; Tina Agander; Benedicte Parm Ulhøi; Birgitte Charabi; Tejs Ehlers Klug; Henrik Jacobsen; Jørgen Johansen; Claus Andrup Kristensen; Elo Andersen; Maria Andersen; Simon Andreasen; Kristine Bjørndal
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-20       Impact factor: 2.503

Review 3.  Value and Quality of Care in Head and Neck Oncology.

Authors:  Robert P Takes; Gyorgy B Halmos; John A Ridge; Paolo Bossi; Matthias A W Merkx; Alessandra Rinaldo; Alvaro Sanabria; Ludi E Smeele; Antti A Mäkitie; Alfio Ferlito
Journal:  Curr Oncol Rep       Date:  2020-07-10       Impact factor: 5.075

4.  Awareness and surveillance of radiation treatment schedules reduces head and neck overall treatment time.

Authors:  Rasmus Lübeck Christiansen; Janne Gornitzka; Pia Andersen; Morten Nielsen; Lars Johnsen; Anders Smedegaard Bertelsen; Ruta Zukauskaite; Jørgen Johansen; Christian Rønn Hansen
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2019-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.